Australia, March 28 -- Baxter International Inc., owns the trademark (2578722) for 'NABEXEL' till Aug. 19, 2035.
Status: registered:
Registered/protected
Class: 5 [pharmaceuticals including injectables for treating cancer including breast cancer, pancreatic, and lung cancer; taxanes used in cancer treatment]
Type of Mark: Word
Date of Acceptance: Jan. 19
Registration Advertised: March 27
For further details contact Maxwells Patent & Trade Mark Attorneys Pty. Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2578722.
Disclaimer: Curated by HT Syndication.
